In addition, DCs in the tumor and dLNs demonstrated a significant increase in maturation marker expression including expression of MHC class II (I-Ab) and costimulatory ligand CD86 (B7-2) (Figure 3, F and G). This evidence concerns the gene CD86 and neoplasm.